Betashares Global Healthcare ETF (Currency Hedged) (DRUG.AX)

About Betashares Global Healthcare ETF (Currency Hedged)

Betashares Global Healthcare ETF (Currency Hedged) is a thematic ETF tracking the global healthcare theme, holding 59 positions. This page values what the fund actually holds — a look-through discounted cash flow of every underlying company, weighted by fund weight — refreshed monthly. The management fee shown is the issuer's stated cost.

Holdings from the issuer's published file; prices and fundamentals from Yahoo Finance. General information only.

Betashares Global Healthcare ETF (Currency Hedged) DRUG.AX

Global healthcare · holdings as at 2026-08-31

DRUG.AX
AUD 9.00
Implied fair value
AUD 7.07
vs intrinsic value
-21% (premium)
Coverage
92%
Management fee
0.57%
Holdings
59

Look-through valuation

Betashares Global Healthcare ETF (Currency Hedged)'s holdings collectively trade 21% above their combined intrinsic value — an implied fair value of about AUD 7.07 versus AUD 9.00 today.

Based on 53 of 59 valued holdings, 92% of fund weight; 6 unvalued. 1st of 10 thematic ETFs by look-through value.

Priciest holding ASTRAZENECA PLC-100% (premium)
Cheapest holding BAYER AG+82% (discount)

Holdings we can value top 15 by weight

WeightHoldingModelvs intrinsic value
8.5% JOHNSON & JOHNSON DCF -19% (premium)
7.5% ELI LILLY & CO DCF -74% (premium)
6.4% ABBVIE INC DCF -24% (premium)
5.0% UNITEDHEALTH GROUP INC DCF +4% (discount)
4.9% ROCHE HOLDING AG DCF +28% (discount)
4.5% MERCK & CO INC DCF -1% (premium)
3.6% THERMO FISHER SCIENTIFIC INC DCF -77% (premium)
3.2% AMGEN INC DCF -39% (premium)
3.1% ASTRAZENECA PLC DCF -100% (premium)
2.8% ABBOTT LABORATORIES DCF -43% (premium)
2.5% GILEAD SCIENCES INC DCF +34% (discount)
2.4% PFIZER INC DCF +71% (discount)
2.2% DANAHER CORP DCF -74% (premium)
2.2% BRISTOL-MYERS SQUIBB CO DCF +64% (discount)
2.0% INTUITIVE SURGICAL INC DCF -62% (premium)

Remaining 38 valued holdings (29% of fund) collectively trade 17% above their combined intrinsic value.

What the fund holds

By sector

  • Healthcare 99.2%
  • Consumer Staples 0.8%

By country

  • United States 75.8%
  • Switzerland 6.3%
  • United Kingdom 5.6%
  • Japan 2.9%
  • France 2.6%
  • Denmark 2.5%
  • Hong Kong 1.9%
  • Belgium 1.3%

From the issuer's published holdings file.

Sister ETFs ≥30% holdings overlap

How this is calculated

Each holding is valued with the same engine behind KashVector's DCF tool and its undervalued screens — a conservative 5-year discounted cash flow, or a dividend / excess-return model for banks, insurers and regulated utilities, or an EV/Sales comparison for a small tail the cash-flow models can't value. Where the DCF needs a forward growth rate we use the slower of a holding's multi-year revenue trend and its multi-year free-cash-flow trend, so one distorted year at one company can't skew the fund's number. Each holding's premium or discount to its own intrinsic value is weighted by fund weight and summed.

Read this as a measurement, not a verdict. The 5-year DCF is deliberately conservative on growth, so a premium is partly the model's own caution. Fast-growing and AI-exposed holdings in particular can read as heavily overvalued because a short-horizon cash-flow model can't capture a genuine platform shift or growth that currently shows up as investment rather than free cash flow. A fund can also trade above a conservative intrinsic value for years while compounding. A point-in-time snapshot as at 2026-09-01, highly sensitive to assumptions. Not financial advice.

Frequently asked questions

Does Betashares Global Healthcare ETF (Currency Hedged) trade above or below the value of what it holds?

As at 2026-09-01, its holdings collectively trade 21% above their combined intrinsic value, over 92% of fund weight. A mechanical measurement, not advice.

Does a premium mean I should sell?

No. Nothing here is financial advice and it is never a buy, sell or hold call. A theme can trade above a conservative intrinsic value for a long time while still compounding.

Why do the tech / AI holdings read as so overvalued?

A 5-year discounted cash flow can't price a genuine platform shift, and it penalises companies whose growth currently shows up as capital investment rather than free cash flow. It reflects the model's limitation as much as the price.

How often is this updated?

Monthly. Holdings come from the issuer's published full-holdings file; prices and fundamentals are a monthly snapshot from Yahoo Finance, not a live feed.